- >
- Blog
- >
- Uncategorized
- >
- Page 2
At its core, Neuland’s philosophy is to meet or exceed quality levels defined by the customer, while also meeting stringent international standards. With multiple customer projects in the works at…
A genotoxic impurity (GTI) is a chemical substance that can directly or indirectly damage DNA or chromosomes and induce genetic mutations. Fifteen years ago, there were no specific guidelines for…
It’s a common misconception that process chemistry refers strictly to process scale-up. While it’s true that process chemistry is a crucial component of optimizing the scale up of an active…
Big Data Brings Insights…and Complexities I recently read an interesting article at ContractPharma.com on pharma companies leveraging Big Data to improve their contracting strategies. Our collective ability to identify, capture,…
7 ways to boost profits and reduce pharma synthesis waste At Neuland, we’re advocates of green chemistry. Not only is it better for the environment, but it’s also just logistically…
Neuland’s Technology Transfer team wrote a piece that was published back in 2011 in Pharmaceutical Technology on the topic of pharma manufacturing and energy efficiency. Since its publication, the issue…
There have been some tremendous gains made in the pharma industry’s understanding of Active Pharmaceutical Ingredient (API) design, and it’s reflected in the APIs currently in development around the globe….
I hope everyone had a great summer! We’ve certainly kept busy. We started July with our rebranding, and spent the summer manufacturing plenty of APIs, drugs and peptides. And while…
Intellectual property rights have always been integral to negotiations for pharmaceutical contract manufacturing services, but growing complexities surrounding global IP issues, complex science, inevitable process improvements, IT infrastructure & security,…
Bromination? Diazotization? Oxidation? Methylation? Niche chemistry is critical to the success of most therapeutics – whether it’s a cardiovascular, anti-fungal, anti-emetic, CNS, Parkinson’s or other drug. Pharmaceutical companies continue to…
